ArticleCommunications biology2025
Improving brain difference identification in autism spectrum disorder through enhanced head motion correction in ICA-AROMA.
Article in Communications biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Cholinergic network disruptions on cognitive function across the spectrum of cognitive impairment in Parkinson's disease.Journal of neurology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Head motion during magnetic resonance imaging (MRI) examinations of patients with autism spectrum disorder (ASD) can influence the identification of brain differences as well as early diagnosis and precise MRI-based interventions for ASD. This study aims to address head motion issues in resting-state functional MRI (rs-fMRI) data by comparing various correction methods. Specifically, we evaluate the independent component analysis-based automatic removal of motion artifacts (ICA-AROMA) against traditional preprocessing pipelines, including head motion realignment parameters and global signal regression (GSR). Our dataset consisted of 306 participants, including 148 individuals with ASD and 158 participants with typical development (TD). We find that ICA-AROMA, particularly when combined with GSR and physiological noise correction, outperformed other strategies in differentiating ASD from TD participants based on functional connectivity (FC) analyses. The correlation of quality control with functional connectivity (QC-FC) is statistically significant in proportion and distance after applying each denoising pipeline. The mean FC between groups is significant for Yeo's 17-Network in each denoising strategy. ICA-AROMA head motion correction outperformed other strategies, revealing more significant FC networks and distinct brain regions linked to the posterior cingulate cortex and postcentral gyrus. This suggests ICA-AROMA enhances fMRI preprocessing, aiding ASD diagnosis and biomarker development.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.